Editor's key points † In this paper, data on 2049 uses of i-gel have been presented. † The overall success rate was 96% and average leak pressure 26 mm Hg. † The risk factors for failure were male gender, impaired mandibular subluxation, poor dentition, and old age. † Importantly, the study provides a large retrospective data on i-gel usage in the everyday clinical setting.
The i-gel TM (Intersurgical Ltd, Wokingham, Berkshire, UK) is a supraglottic airway device that features a non-inflatable cuff and the possibility to introduce a gastric catheter. Its successful use has been described in randomized controlled studies, 1 2 including studies showing the possibility to intubate through the i-gel. 3 4 However, large prospective data about the application in daily clinical practice, side-effects, and possible predictors of i-gel failure are lacking. In order to describe rare adverse events and to find risk factors for failure, observational trials may be preferable to randomized clinical trials. 5 Only relatively small observational evaluations have been published: the largest one is a short communication about an audit of 300 cases. 6 We performed a prospective multicentre observational study in a variety of patients and surgical indications in order to obtain data about the i-gel's clinical performance, risk factors for failure, and adverse events in an everyday clinical setting.
Methods
This observational study was approved by the relevant Swiss Institutional Review Boards for each region (Cantonal Ethics Committee Bern, Bern, and Commission Cantonale Valaisanne d'Éthique Médicale, Sion). Because of the observational nature of the study, the Ethics Committees provided a waiver of patients' consent. We prospectively evaluated all i-gel insertions in five independent hospitals from the French-and the German-speaking part of Switzerland over a period of 24 months. The study did not influence the anaesthesia provider regarding the indication for the device or the mode of its use. The type of anaesthesia induction, maintenance, emergence, and ventilation mode were left to the discretion of the anaesthesia consultant. After anaesthesia, the anaesthesia provider filled out a two-page evaluation form that was attached to the i-gel device. The first page of this questionnaire was regarding the information about the patient, the surgical procedure, and the performance of the supraglottic airway device, as further described below. The second page was filled out in the case of failure of the device. All patients in whom an i-gel was used as the initial airway device were included in the study. Data obtained included patient characteristics (age, sex, height, and weight), airway assessment, surgical specialty, positioning of the patient, and data about the anaesthesia provider (experience with device). Initial i-gel size chosen was based on the manufacturer's recommendation based on body weight. The i-gel was evaluated in regard to the following points: ease of insertion graded from 1 (very easy) to 5 (very difficult), the use of minor airway manoeuvres (changing insertion depth or head/neck position) to correct improper seal, the ease of insertion of a catheter through the oesophageal port and whether gastric contents could be suctioned, the mode of ventilation (spontaneous, controlled, or pressure support), and the duration of anaesthesia. Airway leak pressure was measured as previously recommended, 7 with a maximum allowed pressure of 40 cm H 2 O. Success was defined as insertion of the device and the ability to deliver adequate tidal volumes. In the case of i-gel failure, the anaesthesia provider described the cause of the failure in detail. 
Results
Over a period of 24 months, we prospectively collected and analysed data from 2049 i-gel uses. Another five data sheets could not be analysed because of insufficient data. Patient characteristics, type of surgery, and patients' positions during surgery are listed in Table 1 .
A size 3 i-gel was used in 197 cases (10%), size 4 in 1531 cases (75%), and size 5 in 249 cases (12%). Seventy-two (4%) data sets did not indicate i-gel size.
Data regarding i-gel performance and alternative airway management in the case of failure of the primarily chosen i-gel are summarized in Table 2 . A total of 1914 (93.4%) i-gel devices were successful without changing the size of the device (primary success rate); 135 devices failed initially. In 52 of these failures (2.5%), changing the size of the i-gel was sufficient to achieve a patent airway. Successful ventilation was therefore established by an i-gel device of some size in 1966 (95.9%) cases (overall success rate). The mean airway leak pressure was 26 (8) In 65 of 1966 cases (3.3%), the i-gel was removed before the end of surgery. In 48 cases (2.4%), this was planned and the i-gel served as a guide for fibreoptic intubation. In 17 (1%) cases, this was not planned and the i-gel was removed for either surgical or patient-related reasons such as uncontrollable hiccup.
In total, 47 cases (2.3%) of sore throat were reported. Throughout the period of observation, a total of 25 cases of laryngo-/bronchospasms were reported (1.2%). One case of vagal reflex bradycardia followed by asystole during i-gel insertion was reported. Cardiopulmonary resuscitation was initiated and atropine administered, with return of spontaneous circulation after 1 min. Despite chest compressions, ventilation was successfully maintained with the i-gel in place throughout the episode. The patient was young and healthy and showed no signs of neurological or cardiac sequelae after emergence from anaesthesia. One case of bilateral paraesthesia at the tip of the tongue persisted after operation for 2 months and one case of transient glossopharyngeal nerve impairment was reported. Lastly, one case of glottic haematoma was encountered after an uneventful insertion of an i-gel. The patient showed marked sore throat and pain upon swallowing. ENT consultation revealed a glottic haematoma that was treated symptomatically and resolved after 2 days without long-term sequelae. Table 3 lists data about the anaesthesia providers who inserted the i-gel. All providers were under surveillance of a consultant anaesthesiologist. Airway leak pressure was not influenced by experience with the i-gel (P¼0.18). There was no correlation between experience with the i-gel and percentage of airway manoeuvres necessary (P¼0.12), or difficulty of insertion (P¼0.51). There was a negative correlation between experience with the i-gel and success rate i-gel in 2049 patients (P¼0.002), meaning more experienced providers were less likely to succeed.
The stepwise regression revealed the independent factors predicting i-gel failure reported in Table 4 .
Discussion
This observational prospective multicentre study confirmed the high success rates and airway leak pressures obtained with use of the i-gel that have previously been described in a smaller number of patients. The 93% first-attempt and 96% overall success rate are similar to other secondgeneration supraglottic airway devices like the LMA ProSeal. 8 The leak pressures obtained were comparable with our earlier findings. 2 4 9 The i-gel provided leak pressures in the upper range of comparable supraglottic airway devices, but not as high as the ProSeal Laryngeal Mask. 10 The insertion of an i-gel is found difficult during its passage past the teeth and the tongue, 2 11 or passage through the hypopharyngeal curvature. Therefore, a slightly off-midline approach 2 or depressing the tongue with the thumb 11 has been advocated. In addition, this study showed the difference between successful insertion and successful ventilation: in over 90%, the anaesthesia provider graded insertion as 'very easy' or 'easy', and insertion was possible in 98% of all cases without changing i-gel size. Despite successful insertion, in 103 cases (5%), sufficient ventilation could not be established.
One of the intentions of our study was to find risk factors associated with primary i-gel failure, leading to either change of size or change of device. We found that males, older age, poor dentition, and impaired mandibular subluxation made primary i-gel success less likely. Some of these risk factors have been described for difficult facemask ventilation as well. 12 13 Males and poor dentition have also been identified as risk factors for Laryngeal Mask Airway TM failure in a recent study.
14 This overlap of risk factors for difficult mask ventilation and risk factors for difficult ventilation with a supraglottic airway raises concerns because supraglottic airway devices are often used as back-up devices when the primary airway management attempt fails. Furthermore, these findings also suggest that the correct size of a supraglottic airway device does not only depend on weight, but perhaps also on height, age, and sex. Interestingly, neither weight nor BMI were identified as risk factors for i-gel failure. Therefore, the i-gel could be used as a guide for fibreoptic intubation in overweight patients. As expected, the supine position was most often used, but we also report the successful use of the i-gel in the beach chair, lateral and prone positions. The use of supraglottic airway devices in positions other than supine is under discussion in the anaesthesia community, as experienced providers continue to expand the use of supraglottic airway devices. 15 -17 One feature of the i-gel is the possibility of gastric access via insertion of a gastric catheter. Corroborant to our earlier findings, 18 the gastric catheter suctioned gastric fluids in more than half of the patients despite the fact that all cases were elective, and all patients had fasted for .6 h. Pulmonary aspiration of gastric contents was not reported in any of the 2049 patients. However, the importance of gastric access for the prevention of aspiration remains unknown. 19 In this study, a negative correlation between the experience of the provider and success rate was found. One likely explanation is that less experienced providers predominantly managed patients with 'easy' airways. Another explanation is that experienced providers were taking over at a certain point if the i-gel insertion was difficult, and the last provider dealing with the airway was recorded as the responsible provider. This would also explain why consultants performed more airway manoeuvres compared with Certified Registered Nurse Anesthetists (CRNAs) and Student Registered Nurse Experience with i-gel † 0-1 times used before 171 (9) 2-5 times used before 372 (18) 6-9 times used before 252 (13) 10 -20 times used before 59 (3)
.20 times used before 1131 (57) Anesthetists (SRNAs) and why they were less likely to state that an insertion was easy. The high success rates in novices might also be a result of the apparent easy handling of the airway device. This would suggest either the absence of a learning curve or perhaps a very steep learning curve necessary to gain proficiency with this supraglottic airway device. Among the adverse events that were noted, transient laryngospasms and bronchospasms were most common. In our view, this relates more to episodes of light anaesthesia than to the use of the supraglottic airway devices. 8 Only 47 (2.3%) sore throats were reported. We believe that sore throat was underreported because the severity of sore throat was not evaluated and therefore might not have been reported at all if mild. Of the 2049 cases analysed, two incidents of nerve damage were encountered: in one case, the tip of the tongue got caught between the i-gel and the lower teeth. This caused a bilateral numbness that recovered fully within 2 months. Although we did not specifically evaluate this problem, the relatively bulky construction of the i-gel quite frequently causes the tongue to protrude outwards and to be clenched between the teeth and the i-gel. We recommend to specifically check for this when securing the i-gel in order to avoid entrapment. Perhaps, the protrusion of the tongue occurs in other supraglottic airway devices as well, but there are no reports specifically addressing this issue. The second neurological impairment reported was damage to the glossopharyngeal nerve, which was confirmed by a neurologist. The patient recovered fully within 1 month. In this overweight patient, an i-gel size 5 was initially placed, but as explained above, we believe that the choice of the i-gel should not be made primarily according to weight, but rather according to height, sex, and age. In order to minimize pressure presumably caused by the i-gel, we would recommend using the smallest sized i-gel that provides enough airway seal pressure, especially in overweight patients and for prolonged procedures. However, according to a recent study, 20 mucosal pressures during i-gel use are generally low and not different than during the use of other supraglottic devices.
In conclusion, the i-gel proved to be a reliable supraglottic airway device with a high mean airway leak pressure of 26 (8) cm H 2 O and a high overall insertion and ventilation success rate of 96%, in a broad variety of patients, patient positions, and modes of ventilation. Male sex, older age, poor dentition, and impaired mandibular subluxation were identified as risk factors for i-gel failure. Corrective minor airway manoeuvres were necessary in about one-fifth of all cases. Adverse events were rare; they included laryngeal spasms, transient nerve damage, haematoma, and vagal responses.
